Spots Global Cancer Trial Database for solid tumour refractory
Every month we try and update this database with for solid tumour refractory cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats | NCT01078662 | Ovarian Breast Prostate Pancreatic Advanced Tumour... | olaparib | 18 Years - 130 Years | AstraZeneca | |
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats | NCT01078662 | Ovarian Breast Prostate Pancreatic Advanced Tumour... | olaparib | 18 Years - 130 Years | AstraZeneca |